Keyphrases
Activity in Vivo
12%
Amygdala
50%
Amygdala Circuit
100%
Basolateral Amygdala
12%
Brain Regions
12%
Brain-derived Neurotrophic Factor
12%
Circuitry
12%
Corticostriatal Circuits
12%
Dysregulated
12%
Dysregulated Expression
12%
Electrophysiological Measurements
12%
ERK MAPK
100%
Facial Skin
12%
Factor Level
12%
Fluoxetine
12%
Gene Transcription
12%
Gene Variation
12%
Grooming
12%
Increased Activity
12%
Intrusive Thoughts
12%
Knock-in Mouse Model
50%
Mediating Mechanism
12%
MEK Inhibitor (MEKi)
12%
Morphological Difference
12%
Neuropsychiatric Diseases
12%
Obsessive-compulsive Disorder
100%
Overactivation
12%
Pathway Activity
12%
Potent Inhibitor
12%
Preprotein
12%
Ras-ERK
12%
Ritual Behaviour
12%
Rodents
12%
Selective Serotonin Reuptake Inhibitors
12%
Self-grooming
12%
Selumetinib
12%
Skin Lesions
12%
SPRED2
100%
Synapse
25%
Synaptic Function
12%
Synaptic Proteins
25%
Synaptic Transmission
12%
Thalamocortical Circuit
12%
Tropomyosin Receptor Kinase B
100%
INIS
brain
40%
diseases
20%
genes
40%
in vivo
20%
kinases
100%
knock-out reactions
80%
levels
20%
mice
100%
neurons
20%
pathogenesis
40%
populations
20%
proteins
40%
receptors
100%
rodents
20%
serotonin
20%
skin
20%
transcription
20%
transmission
40%
tropomyosin
100%
variations
20%
Neuroscience
Amygdala
100%
Behavior (Neuroscience)
100%
Brain-Derived Neurotrophic Factor
14%
Fluoxetine
14%
Genetic Transcription
14%
In Vivo
14%
Intrusive Thoughts
14%
Kinase
100%
MAPK Signaling
100%
MAPK/ERK Pathway
14%
MEK Inhibitor
14%
Obsessive-Compulsive Disorder
100%
Receptor
100%
Selective Serotonin Reuptake Inhibitor
14%
Selumetinib
14%
Synapse
28%
Synaptic Transmission
14%
Tropomyosin
100%